Dexverapamil to overcome epirubicin resistance in advanced breast cancer.
Thürlimann B, Kröger N, Greiner J, Mross K, Schüller J, Schernhammer E, Schumacher K, Gastl G, Hartlapp J, Kupper H, et al.
Thürlimann B, et al.
J Cancer Res Clin Oncol. 1995;121 Suppl 3:R3-6. doi: 10.1007/BF02351063.
J Cancer Res Clin Oncol. 1995.
PMID: 8698740
Clinical Trial.